PROFUSA, INC. Deferred Income Tax Liabilities, Net
PROFUSA, INC. (PFSA) had Deferred Income Tax Liabilities, Net of $13.66 thousand as of 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2025-03-31
- 2023-12-31: Deferred Income Tax Liabilities, Net $13.66K.
- 2022-12-31: Deferred Income Tax Liabilities, Net $36.94K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2023-12-31 | $13.66K 10-K · filed 2025-03-31 |
| 2022-12-31 | $36.94K 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |